Pharmagreen Biotech Inc. (PHBI) SEC Filing 10-K Annual Report for the fiscal year ending Friday, September 30, 2022

Pharmagreen Biotech Inc.

CIK: 1435181 Ticker: PHBI
Cover - USD ($)
12 Months Ended
Sep. 30, 2022
Jan. 16, 2023
Mar. 31, 2022
Cover [Abstract]   
Entity Registrant NamePHARMAGREEN BIOTECH INC.  
Entity Central Index Key0001435181  
Document Type10-K  
Amendment Flagfalse  
Entity Voluntary FilersYes  
Current Fiscal Year End Date--09-30  
Entity Well Known Seasoned IssuerNo  
Entity Small Businesstrue  
Entity Shell Companyfalse  
Entity Emerging Growth Companyfalse  
Entity Current Reporting StatusYes  
Document Period End DateSep. 30, 2022  
Entity Filer CategoryNon-accelerated Filer  
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2022  
Entity Common Stock Shares Outstanding 454,760,969 
Entity Public Float  $ 6,505,862
Document Annual Reporttrue  
Document Transition Reportfalse  
Entity File Number000-56090  
Entity Incorporation State Country CodeNV  
Entity Tax Identification Number98-0491567  
Entity Address Address Line 12987 Blackbear Court  
Entity Address City Or TownCoquitlam  
Entity Address State Or ProvinceBC  
Entity Address Postal Zip CodeV3E 3A2  
City Area Code702  
Icfr Auditor Attestation Flagfalse  
Local Phone Number803-9404  
Security 12b TitleCommon stock  
Trading SymbolPHBI  
Entity Interactive Data CurrentNo  
Auditor Firm Id3627  
Auditor NameSadler, Gibb & Associates, LLC  
Auditor LocationDraper, UT  

View differences made from one year to another to evaluate Pharmagreen Biotech Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Pharmagreen Biotech Inc..


Assess how Pharmagreen Biotech Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Pharmagreen Biotech Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations And Comprehensive Loss
Consolidated Statements Of Stockholders' Deficit
Accounts Payable And Accrued Liabilities
Accounts Payable And Accrued Liabilities (Details)
Accounts Payable And Accrued Liabilities (Tables)
Commitments And Contigency (Details Narrative)
Commitments And Contingency
Common Stock
Common Stock (Details Narrative)
Convertible Notes
Convertible Notes (Details Narrative)
Derivative Liabilities
Derivative Liabilities (Tables)
Derivative Liability (Details 1)
Derivative Liability (Details)
Income Taxes
Income Taxes (Details 1)
Income Taxes (Details 2)
Income Taxes (Details Narrative)
Income Taxes (Details)
Income Taxes (Tables)
Loan Payable
Loans Payable (Details Narrative)
Memorandum Of Understanding
Memorandum Of Understanding (Details Narrative)
Nature Of Business And Continuance Of Operations
Nature Of Business And Continuance Of Operations (Details Narrative)
Preferred Stock
Preferred Stock (Details Narrative)
Related Party Transactions
Related Party Transactions (Details Narrative)
Share Purchase Warrants
Share Purchase Warrants (Details 1)
Share Purchase Warrants (Details)
Share Purchase Warrants (Tables)
Significant Accounting Policies
Significant Accounting Policies (Details Narrative)
Significant Accounting Policies (Details)
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Subsequent Events
Subsequent Events (Details Narrative)

Material Contracts, Statements, Certifications & more

Pharmagreen Biotech Inc. provided additional information to their SEC Filing as exhibits

Ticker: PHBI
CIK: 1435181
Form Type: 10-K Annual Report
Accession Number: 0001477932-23-000296
Submitted to the SEC: Tue Jan 17 2023 6:10:35 AM EST
Accepted by the SEC: Tue Jan 17 2023
Period: Friday, September 30, 2022
Industry: Airports Flying Fields And Airport Terminal Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: